Facilitators and Barriers to Latent Tuberculosis Infection Treatment Among Primary Healthcare Workers in Malaysia: a Qualitative Study

Overview

Journal BMC Health Serv Res

Publisher Biomed Central

Specialty Health Services

Date 2023 Aug 29

PMID 37644513

Authors

Siti Nur Farhana H

Anusha Manoharan

Wen Ming Koh

Manimaran K

Ee Ming Khoo

Affiliations

Soon will be listed here.

Abstract

Background: Healthcare workers (HCWs) have an increased risk of active and latent tuberculosis infection (LTBI) compared to the general population. Despite existing guidelines on the prevention and management of LTBI, little is known about why HCWs who tested positive for LTBI refuse treatment. This qualitative study sought to explore the facilitators and barriers to LBTI treatment uptake among primary HCWs in Malaysia.

Methods: This qualitative study used a phenomenological research design and was conducted from July 2019 to January 2021. A semi-structured topic guide was developed based on literature and the Common-Sense Model of Self-Regulation. We conducted one focus group discussion and 15 in-depth interviews with primary care HCWs. Interviewees were 7 physicians and 11 allied HCWs who tested positive for LTBI by Tuberculin Skin Test or Interferon Gamma Release Assay. Audio recordings were transcribed verbatim and thematic analysis was used to analyse the data.

Results: We found four factors that serve as barriers to HCWs' LTBI treatment uptake. Uncertainties about the need for LTBI treatment, alongside several other factors including the attitude of the treating physician towards treatment, time constraints during clinical consultations, and concerns about the treatment itself. On the other hand, facilitators for LTBI treatment uptake can be grouped into two themes: diagnostic modalities and improving knowledge of LTBI treatment.

Conclusions: Improving HCWs' knowledge and informative clinical consultation on LTBI and its treatment benefit, aided with a definitive diagnostic test can facilitate treatment uptake. Additionally, there is a need to improve infection control measures at the workplace to protect HCWs. Utilizing behavioural insights can help modify risk perception among HCWs and promote treatment uptake.

Citing Articles

Prevalence of latent tuberculosis infection (LTBI) in healthcare workers in Latin America and the Caribbean: systematic review and meta-analysis.

Meregildo-Rodriguez E, Ortiz-Pizarro M, Asmat-Rubio M, Rojas-Benites M, Vasquez-Tirado G Infez Med. 2024; 32(3):292-311.

PMID: 39282545 PMC: 11392545. DOI: 10.53854/liim-3203-4.

References

Spence B, Bruxvoort K, Munoz-Plaza C, Shaw S, Navarro M, Chen H . Patient-Reported Barriers to Treatment Initiation and Completion for Latent Tuberculosis Infection Among Patients Within a Large Integrated Health Care System in Southern California. J Public Health Manag Pract. 2023; 29(3):345-352. PMC: 10038844. DOI: 10.1097/PHH.0000000000001711. View

Alsdurf H, Hill P, Matteelli A, Getahun H, Menzies D . The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. Lancet Infect Dis. 2016; 16(11):1269-1278. DOI: 10.1016/S1473-3099(16)30216-X. View

Klautau G, da Mota N, Salles M, Burattini M, Rodrigues D . Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study. BMC Infect Dis. 2018; 18(1):585. PMC: 6245697. DOI: 10.1186/s12879-018-3508-8. View

Apriani L, McAllister S, Sharples K, Alisjahbana B, Ruslami R, Hill P . Latent tuberculosis infection in healthcare workers in low- and middle-income countries: an updated systematic review. Eur Respir J. 2019; 53(4). DOI: 10.1183/13993003.01789-2018. View

Napoli C, Ferretti F, Di Ninno F, Orioli R, Marani A, Sarlo M . Screening for Tuberculosis in Health Care Workers: Experience in an Italian Teaching Hospital. Biomed Res Int. 2017; 2017:7538037. PMC: 5350285. DOI: 10.1155/2017/7538037. View

Heyd A, Heffernan C, Storey K, Wild T, Long R . Treating latent tuberculosis infection (LTBI) with isoniazid and rifapentine (3HP) in an inner-city population with psychosocial barriers to treatment adherence: A qualitative descriptive study. PLOS Glob Public Health. 2023; 1(12):e0000017. PMC: 10021900. DOI: 10.1371/journal.pgph.0000017. View

Paton N, Borand L, Benedicto J, Kyi M, Mahmud A, Norazmi M . Diagnosis and management of latent tuberculosis infection in Asia: Review of current status and challenges. Int J Infect Dis. 2019; 87:21-29. DOI: 10.1016/j.ijid.2019.07.004. View

Barss L, Moayedi-Nia S, Campbell J, Oxlade O, Menzies D . Interventions to reduce losses in the cascade of care for latent tuberculosis: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2020; 24(1):100-109. DOI: 10.5588/ijtld.19.0185. View

Arguello Perez E, Seo S, Schneider W, Eisenstein C, Brown A . Management of Latent Tuberculosis Infection Among Healthcare Workers: 10-Year Experience at a Single Center. Clin Infect Dis. 2017; 65(12):2105-2111. PMC: 5850550. DOI: 10.1093/cid/cix725. View

10.

Sharma D, Sharma J, Deo N, Bisht D . Prevalence and risk factors of tuberculosis in developing countries through health care workers. Microb Pathog. 2018; 124:279-283. DOI: 10.1016/j.micpath.2018.08.057. View

11.

Edet A, Turner S . Factors associated with positive Mantoux results in NHS healthcare workers. Occup Med (Lond). 2018; 68(4):286-289. DOI: 10.1093/occmed/kqy051. View

12.

Namgung S, Jung J, Kim S, Kim E, Jo K, Shim T . Incidence of tuberculosis infection in healthcare workers in high-risk departments for tuberculosis after universal wearing of KF94 mask during COVID-19 pandemic. J Infect. 2023; 87(4):344-345. PMC: 10029346. DOI: 10.1016/j.jinf.2023.03.017. View

13.

Ledda C, Cina D, Garozzo S, Senia P, Consoli A, Marconi A . Tuberculosis screening among healthcare workers in Sicily, Italy. Future Microbiol. 2019; 14:37-40. DOI: 10.2217/fmb-2018-0265. View

14.

Nathavitharana R, van der Westhuizen A, van der Westhuizen H, Mishra H, Sampson A, Meintjes J . "If I've got latent TB, I would like to get rid of it": Derivation of the CARD (Constraints, Actions, Risks, and Desires) Framework informed by South African healthcare worker perspectives on latent tuberculosis treatment. PLoS One. 2021; 16(8):e0254211. PMC: 8372902. DOI: 10.1371/journal.pone.0254211. View

15.

Dobler C, Martin A, Marks G . Benefit of treatment of latent tuberculosis infection in individual patients. Eur Respir J. 2015; 46(5):1397-406. DOI: 10.1183/13993003.00577-2015. View

16.

Pless A, McLennan S, Nicca D, Shaw D, Elger B . Reasons why nurses decline influenza vaccination: a qualitative study. BMC Nurs. 2017; 16:20. PMC: 5410084. DOI: 10.1186/s12912-017-0215-5. View

17.

Schablon A, Nienhaus A, Ringshausen F, Preisser A, Peters C . Occupational screening for tuberculosis and the use of a borderline zone for interpretation of the IGRA in German healthcare workers. PLoS One. 2014; 9(12):e115322. PMC: 4277296. DOI: 10.1371/journal.pone.0115322. View

18.

Uden L, Barber E, Ford N, Cooke G . Risk of Tuberculosis Infection and Disease for Health Care Workers: An Updated Meta-Analysis. Open Forum Infect Dis. 2017; 4(3):ofx137. PMC: 5575844. DOI: 10.1093/ofid/ofx137. View

19.

Swift M, Molella R, Vaughn A, Breeher L, Newcomb R, Abdellatif S . Determinants of Latent Tuberculosis Treatment Acceptance and Completion in Healthcare Personnel. Clin Infect Dis. 2019; 71(2):284-290. DOI: 10.1093/cid/ciz817. View

20.

Stuurman A, Vonk Noordegraaf-Schouten M, van Kessel F, Oordt-Speets A, Sandgren A, van der Werf M . Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review. BMC Infect Dis. 2016; 16:257. PMC: 4897858. DOI: 10.1186/s12879-016-1549-4. View